[1] Nicholas J, William U, Rebecca H, et al. Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the massachusetts general hospital experience[J]. Eur Urol, 2017,71:952-960.
[2] 范欣荣,李汉忠,纪志刚,等. 保留器官的综合治疗-膀胱癌治疗的新模式(附107例报告)[J].中华泌尿外科杂志,2016,37(2):131-134.
[3] Leow J J, Martin D W, Rajagopal P S, et al. Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials[J]. Eur Urol, 2014,66(1):42-54.
[4] James N D, Hussain S A, Hall E, et al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer[J]. N Engl J Med, 2012, 366(16):1477-1488.
[5] Solsona E, Climent M A, Iborra I, et al. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy:long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy[J]. Eur Urol, 2009,55(4):911-999.
[6] 王 华,李怀康. 诊断性电切术确诊膀胱Burkitt淋巴瘤1例[J].武警医学,2019,30(11):983-984.